The findings are notable in part because therapies have already been approved to target C5aR1 in other diseases.

There are two main types of esophageal cancer: Squamous cell carcinoma. Squamous cells line the inner esophagus, and cancer developing from squamous cells can occur along the entire esophagus.

Esophageal squamous cell carcinoma (ESCC) is a highly aggressive ... has been implicated in cancer development, but its precise role in ESCC has been unclear. HNRNPC, known for its role in pre ...

When it comes to the use of PD-1 inhibitors in stomach cancer, the FDA has put its money where its mouth is. | After ...

The stages of squamous cell carcinoma (SCC) range from 0 to 4. At stage 0, there are atypical cells that are not yet cancerous, which may or may not be visible. By stage 4, the cancer may be large ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Samuel J.

Among individuals with achalasia, male sex, older age and prior esophageal Candida infection increased risk for esophageal ...

in combination with chemotherapy for the first-line treatment of esophageal squamous cell carcinoma (ESCC) and gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. “Patients diagnosed ...

Esophageal cancer remains one of the world's deadliest cancers, ranking 7th in incidence and 6th in cancer-related deaths ...

Researchers are also investigating the PD-1 immune checkpoint inhibitor as treatment before surgical and radiation treatment.

Adjuvant nivolumab offered sustained survival benefits in resected esophageal/GEJ cancer post chemoradiation, with PD-L1 ...

Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified ...